Literature DB >> 29606500

Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease.

Erin L Murphy1, Madeline L Droher1, Miriam S DiMaio2, Neera K Dahl3.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common hereditary forms of chronic kidney disease. Mutations within PKD1 or PKD2 lead to innumerable fluid-filled cysts in the kidneys and in some instances, end-stage renal disease (ESRD). Affected individuals have a 50% chance of passing the mutation to each of their offspring. Assisted reproductive technology using preimplantation genetic diagnosis (PGD) allows these individuals to reduce this risk to 1% to 2%. We assess the disease burden of 8 individuals with ADPKD who have undergone genetic testing in preparation for PGD. Clinical features that predict high risk for progression to ESRD in patients with ADPKD include genotype, early onset of hypertension, a urologic event before age 35 years, and a large height-adjusted total kidney volume. Patients may have a family history of intracranial aneurysms or complications involving hepatic cysts, which may further influence the decision to pursue PGD. We also explore the cost, risks, and benefits of using PGD. All patients with ADPKD of childbearing potential, regardless of risk for progression to ESRD or risk for a significant disease burden, will likely benefit from genetic counseling.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease (ADPKD); PKD1; PKD2; assisted reproductive technology; end-stage renal disease (ESRD); genetic counseling; in vitro fertilization (IVF); linkage analysis; mutation detection; pregnancy; preimplantation genetic diagnosis (PGD)

Mesh:

Year:  2018        PMID: 29606500     DOI: 10.1053/j.ajkd.2018.01.048

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Combined Preimplantation Genetic Testing for Autosomal Dominant Polycystic Kidney Disease: Consequences for Embryos Available for Transfer.

Authors:  Pere Mir Pardo; José Antonio Martínez-Conejero; Julio Martín; Carlos Simón; Ana Cervero
Journal:  Genes (Basel)       Date:  2020-06-24       Impact factor: 4.096

2.  Preimplantation Genetic Testing for Monogenic Kidney Disease.

Authors:  Rozemarijn Snoek; Marijn F Stokman; Klaske D Lichtenbelt; Theodora C van Tilborg; Cindy E Simcox; Aimée D C Paulussen; Jos C M F Dreesen; Franka van Reekum; A Titia Lely; Nine V A M Knoers; Christine E M de Die-Smulders; Albertien M van Eerde
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-27       Impact factor: 8.237

3.  Birth of two healthy girls following preimplantation genetic diagnosis and gestational surrogacy in a rapidly progressive autosomal dominant polycystic kidney disease case using tolvaptan.

Authors:  Ramón Peces; Rocío Mena; Carlos Peces; Emilio Cuesta; Pablo Lapunzina; Rafael Selgas; Julián Nevado
Journal:  Clin Kidney J       Date:  2021-04-25

Review 4.  The wind of change in the management of autosomal dominant polycystic kidney disease in childhood.

Authors:  Charlotte Gimpel; Carsten Bergmann; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2021-03-07       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.